Literature DB >> 32746737

Gene Therapy for Respiratory Diseases: Progress and a Changing Context.

Eric W F W Alton1,2, A Christopher Boyd2,3, Jane C Davies1,2, Deborah R Gill2,4, Uta Griesenbach1,2, Tracy E Harman1,2, Stephen Hyde2,4, Gerry McLachlan2,5.   

Abstract

Entities:  

Year:  2020        PMID： 32746737      PMCID： PMC7499889          DOI： 10.1089/hum.2020.142

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  56 in total

1.  Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view.

Authors:  K De Boeck; T Lee; M Amaral; P Drevinek; J S Elborn; I Fajac; E Kerem; J C Davies
Journal:  J Cyst Fibros       Date:  2020-06-08       Impact factor: 5.482

2.  Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes.

Authors:  Katsuyuki Mitomo; Uta Griesenbach; Makoto Inoue; Lucinda Somerton; Cuixiang Meng; Eiji Akiba; Toshiaki Tabata; Yasuji Ueda; Gad M Frankel; Raymond Farley; Charanjit Singh; Mario Chan; Felix Munkonge; Andrea Brum; Stefania Xenariou; Sara Escudero-Garcia; Mamoru Hasegawa; Eric W F W Alton
Journal:  Mol Ther       Date:  2010-03-23       Impact factor: 11.454

3.  An immunocytochemical assay to detect human CFTR expression following gene transfer.

Authors:  Heather Davidson; Abigail Wilson; Robert D Gray; Alex Horsley; Ian A Pringle; Gerry McLachlan; Angus C Nairn; Cordelia Stearns; James Gibson; Emma Holder; Lisa Jones; Ann Doherty; Rebecca Coles; Stephanie G Sumner-Jones; Marguerite Wasowicz; Michelle Manvell; Uta Griesenbach; Stephen C Hyde; Deborah R Gill; Jane Davies; D David S Collie; Eric W F W Alton; David J Porteous; A Christopher Boyd
Journal:  Mol Cell Probes       Date:  2009-07-15       Impact factor: 2.365

4.  Insights into the variability of nasal potential difference, a biomarker of CFTR activity.

Authors:  Spyridoula Kyrilli; Theophraste Henry; Michael Wilschanski; Isabelle Fajac; Jane C Davies; Jean-Philippe Jais; Isabelle Sermet-Gaudelus
Journal:  J Cyst Fibros       Date:  2019-11-04       Impact factor: 5.482

Review 5.  Gene therapy approaches for inherited and acquired lung diseases.

Authors:  D T Curiel; J M Pilewski; S M Albelda
Journal:  Am J Respir Cell Mol Biol       Date:  1996-01       Impact factor: 6.914

Review 6.  The Promise and Challenge of In Vivo Delivery for Genome Therapeutics.

Authors:  Ross C Wilson; Luke A Gilbert
Journal:  ACS Chem Biol       Date:  2017-10-19       Impact factor: 5.100

Review 7.  Developments in multiple breath washout testing in children with cystic fibrosis.

Authors:  Clare Saunders; Katie Bayfield; Samantha Irving; Christopher Short; Andrew Bush; Jane C Davies
Journal:  Curr Med Res Opin       Date:  2017-02-02       Impact factor: 2.580

8.  Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.

Authors:  Jacqueline Corrigan-Curay; Odile Cohen-Haguenauer; Marina O'Reilly; Susan R Ross; Hung Fan; Naomi Rosenberg; Nikunj Somia; Nancy King; Theodore Friedmann; Cynthia Dunbar; Alessandro Aiuti; Luigi Naldini; Christopher Baum; Christof von Kalle; Hans-Peter Kiem; Eugenio Montini; Frederic Bushman; Brian P Sorrentino; Manuel Carrondo; Harry Malech; Gösta Gahrton; Robyn Shapiro; Linda Wolff; Eugene Rosenthal; Robert Jambou; John Zaia; Donald B Kohn
Journal:  Mol Ther       Date:  2012-06       Impact factor: 11.454

9.  Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

Authors:  Eric W F W Alton; Jeffery M Beekman; A Christopher Boyd; June Brand; Marianne S Carlon; Mary M Connolly; Mario Chan; Sinead Conlon; Heather E Davidson; Jane C Davies; Lee A Davies; Johanna F Dekkers; Ann Doherty; Sabrina Gea-Sorli; Deborah R Gill; Uta Griesenbach; Mamoru Hasegawa; Tracy E Higgins; Takashi Hironaka; Laura Hyndman; Gerry McLachlan; Makoto Inoue; Stephen C Hyde; J Alastair Innes; Toby M Maher; Caroline Moran; Cuixiang Meng; Michael C Paul-Smith; Ian A Pringle; Kamila M Pytel; Andrea Rodriguez-Martinez; Alexander C Schmidt; Barbara J Stevenson; Stephanie G Sumner-Jones; Richard Toshner; Shu Tsugumine; Marguerite W Wasowicz; Jie Zhu
Journal:  Thorax       Date:  2016-11-16       Impact factor: 9.139

Review 10.  Delivering on the promise of gene editing for cystic fibrosis.

Authors:  Craig A Hodges; Ronald A Conlon
Journal:  Genes Dis       Date:  2018-11-25
View more
  1 in total

1.  Aerosol-Mediated Non-Viral Lung Gene Therapy: The Potential of Aminoglycoside-Based Cationic Liposomes.

Authors:  Tony Le Gall; Mathieu Berchel; Lee Davies; Angélique Mottais; Rosy Ghanem; Alain Fautrel; Deborah Gill; Steve Hyde; Pierre Lehn; Jean-Marie Lehn; Loïc Lemiègre; Thierry Benvegnu; Paul-Alain Jaffrès; Bruno Pitard; Tristan Montier
Journal:  Pharmaceutics       Date:  2021-12-23       Impact factor: 6.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.